Accurate staging and thorough work-up, including urine cytology and CT urography, are crucial for optimal UTUC management. Treatment options for low-grade UTUC include active surveillance, endoscopic ...

Canadian provinces exhibit significant disparities in TURP reimbursement rates, with 20%-30% differences and no alignment with the cost-of-living index. Advanced BPH techniques like Greenlight and ...

mCSPC and mHSPC refer to prostate cancer with metastases that remain responsive to hormone therapy, often used interchangeably. Both conditions involve the presence of metastases and sensitivity to ...

Lifestyle modifications, including yoga, hypnosis, and nutraceuticals, are increasingly used in BPH management, reflecting a trend towards integrating alternative medicine with traditional treatments.

Olaparib significantly improved radiographic progression-free survival and overall survival in metastatic prostate cancer with HRR gene alterations. Safety profiles of PARP inhibitors were consistent ...

PRP is popular for Peyronie disease due to its availability and safety, using patients' own biological factors. Limited data exist on PRP's efficacy for Peyronie disease, with studies showing no ...

The study is a large, multi-center, independently funded cohort series on Peyronie's disease treatment satisfaction. Patients who underpredict their penile curvature report higher satisfaction ...

The TALAPRO-2 study authors noted that the use of androgen receptor (AR)–targeted therapy in clinical practice has increased considerably in recent years. How might prior use of AR-targeted therapy ...

"If you tapped into your emergency fund for any reason this year, it is important to make sure the account is replenished," writes Jeff Witz, CFP. This year has been a rollercoaster. Inflation finally ...

Bel-sar is being investigated as an immunoablative agent to potentially replace TURBTs in NMIBC treatment, offering an office-based alternative. Combining bel-sar with cytokine therapies like IL-15 or ...

68Gallium PSMA-11 PET is preferred for confirming lutetium therapy eligibility due to its high specificity in detecting PSMA expression. Alternatives include 18F-DCFPyL PET, which also targets PSMA, ...

The LOBSTER study assesses CxBladder tests for urothelial carcinoma recurrence, aiming to enroll 400-500 patients with 75 confirmed tumors. Participants provide urine samples over 2 years, alternating ...